Kyowa Kirin Co., Ltd.

General ticker "KYKOF" information:

  • Sector: Health Care
  • Industry: Medical - Pharmaceuticals
  • Capitalization: $7.7B (TTM average)

Kyowa Kirin Co., Ltd. follows the US Stock Market performance with the rate: 1.0%.

Estimated limits based on current volatility of 1.8%: low 16.09$, high 16.69$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-06-30, amount 0.22$ (Y1.36%)
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [14.45$, 21.94$]
  • 2026-12-31 to 2027-12-31 estimated range: [15.47$, 23.32$]

Financial Metrics affecting the KYKOF estimates:

  • Positive: with PPE of 18.8 at the end of fiscal year the price was neutral
  • Positive: 15.73 < Operating profit margin, % of 20.59
  • Positive: Inventory ratio change, % of -0.88 <= -0.35
  • Positive: -10.50 < Investing cash flow per share per price, % of -7.14
  • Positive: 6.57 < Operating cash flow per share per price, % of 7.72
  • Positive: 4.89 < Return on assets ratio (scaled to [-100,100]) of 5.71
  • Positive: -66.29 < Industry operating profit margin (median), % of -43.01
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: 0.18 < Interest expense per share per price, % of 0.28

Similar symbols

Short-term KYKOF quotes

Long-term KYKOF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue ¥442,233.00MM ¥495,558.00MM ¥497,259.54MM
Operating Expenses ¥355,794.00MM ¥403,692.00MM ¥394,895.29MM
Operating Income ¥86,439.00MM ¥91,866.00MM ¥102,364.25MM
Non-Operating Income ¥10,807.00MM ¥-8,413.00MM ¥-15,067.14MM
Interest Expense ¥190.00MM ¥7,538.00MM ¥3,647.18MM
R&D Expense ¥81,509.00MM ¥103,544.00MM ¥101,271.29MM
Income(Loss) ¥97,246.00MM ¥83,453.00MM ¥87,297.11MM
Taxes ¥16,058.00MM ¥0.00MM ¥20,199.61MM
Net Income(Loss)* ¥81,188.00MM ¥59,870.00MM ¥67,098.50MM
Stockholders Equity ¥836,418.00MM ¥850,811.00MM ¥894,111.53MM
Inventory ¥71,363.00MM ¥72,933.00MM ¥67,498.85MM
Assets ¥1,025,942.00MM ¥1,067,363.00MM ¥1,108,826.73MM
Operating Cash Flow ¥115,551.00MM ¥67,884.00MM ¥100,103.27MM
Capital expenditure ¥32,852.00MM ¥105,268.00MM ¥41,147.88MM
Investing Cash Flow ¥-20,382.00MM ¥-142,389.00MM ¥-92,666.79MM
Financing Cash Flow ¥-32,535.00MM ¥-84,697.00MM ¥-36,885.16MM
Earnings Per Share** ¥151.01 ¥113.06 ¥128.18

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.